Investor Documents & Presentations
Annual Report & Accounts
General meeting documents
Results Presentations
Other Company Presentations
- How a Lateral Flow Rapid Test Works
- Avacta CEO Alastair Smith provides update on COVID-19 collaboration with Cytiva
- Alastair Smith provides overview of pre|CISION™ prodrug technology and update on AVA6000 clinical trial
- Alastair Smith provides update on AffyXell collaboration and licence agreement
- Alastair Smith provides update on TMAC programme
- An Investor’s Introduction to pre|CISION Chemotherapies
- Corporate Presentation (Therapeutics) Feb 2020
- Joint venture between Avacta and Daewoong
- See more company presentations
Research Notes
Other documents